Upper Limb Morbidity and Quality of Life After Lymph Node Sentinel Biopsy for Breast Cancer Treatment

Detalhes bibliográficos
Autor(a) principal: Velloso, Fernanda Saltiel Barbosa
Data de Publicação: 2009
Outros Autores: Barra, Alexandre de Almeida, Dias, Rosângela Corrêa
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista Brasileira de Cancerologia (Online)
Texto Completo: https://rbc.inca.gov.br/index.php/revista/article/view/1681
Resumo: The second most frequent cancer type worldwide and the most frequent in women is breast cancer. Sentinel lymph node biopsy (SLNB) has become a trend in therapeutic approach nowadays, once it allows disease control with minimal surgical intervention and grants low morbidity rates. This article aims at reviewing literature on musculoskeletal impairments and quality of life among women treated through SLNB for breast cancer. Pubmed, Cochrane, Scielo and Lilacs databases were searched through the years of 1997 to 2008. Medical subject heading terms uses were breast neoplasms, sentinel lymph node biopsy, morbidity and quality of life. Seventy six articles were retrieved and 22 were selected. Results showed the most studied morbidities were sensory disorders (7% to 88% prevalence), pain (3,5% to 39%), lymphedema (0% e 22%), shoulder range of motion impairment (3% to 16%), daily living activities restriction (7,8% to 27,8%) and quality of life deterioration. After 36 months upper limb morbidities hardly seem to interfere with quality of life. Patients have mostly worried about cancer recurrence. Surgery time lapsed and instruments used for data retrieving explain variability in symptoms prevalence. Long term follow-up studies to evaluate morbidities and quality of life research on Brazilian population are missing.
id INCA-1_dee8bfc1ac7d1d3f062fdf2af9abbd27
oai_identifier_str oai:rbc.inca.gov.br:article/1681
network_acronym_str INCA-1
network_name_str Revista Brasileira de Cancerologia (Online)
repository_id_str
spelling Upper Limb Morbidity and Quality of Life After Lymph Node Sentinel Biopsy for Breast Cancer TreatmentMorbidade de Membros Superiores e Qualidade de Vida após a Biópsia de Linfonodo Sentinela para o Tratamento do Câncer de MamaNeoplasias da mamaBiópsia de linfonodo sentinelaMorbidadeQualidade de vidaBreast neoplasmsSentinel lymph node biopsyMorbidityQuality of lifeThe second most frequent cancer type worldwide and the most frequent in women is breast cancer. Sentinel lymph node biopsy (SLNB) has become a trend in therapeutic approach nowadays, once it allows disease control with minimal surgical intervention and grants low morbidity rates. This article aims at reviewing literature on musculoskeletal impairments and quality of life among women treated through SLNB for breast cancer. Pubmed, Cochrane, Scielo and Lilacs databases were searched through the years of 1997 to 2008. Medical subject heading terms uses were breast neoplasms, sentinel lymph node biopsy, morbidity and quality of life. Seventy six articles were retrieved and 22 were selected. Results showed the most studied morbidities were sensory disorders (7% to 88% prevalence), pain (3,5% to 39%), lymphedema (0% e 22%), shoulder range of motion impairment (3% to 16%), daily living activities restriction (7,8% to 27,8%) and quality of life deterioration. After 36 months upper limb morbidities hardly seem to interfere with quality of life. Patients have mostly worried about cancer recurrence. Surgery time lapsed and instruments used for data retrieving explain variability in symptoms prevalence. Long term follow-up studies to evaluate morbidities and quality of life research on Brazilian population are missing.O câncer de mama é o segundo tipo de câncer mais frequente no mundo e o mais comum entre as mulheres. A tendência atual da abordagem terapêutica é oferecer a mínima intervenção que garanta o controle da doença, menos morbidades e preserve a qualidade de vida (QV). A técnica de biópsia de linfonodo sentinela (BLS) se baseia nessa premissa. Este artigo teve por objetivo revisar a literatura quanto à prevalência de morbidades relativas aos membros superiores e à QV entre pacientes submetidas à BLS. Foram consultadas as bases de dados Pubmed, Cochrane, Scielo e Lilacs entre os anos de 1997 e 2008. Os descritores de assunto utilizados foram Breast neoplasms, Sentinel lymph node biopsy, Morbidity e Quality of life. Foram encontrados 76 artigos e selecionados 22. Os resultados mostraram que as morbidades mais frequentemente estudadas foram alterações de sensibilidade (prevalência entre 7% a 88%), dor (3,5% a 39%), linfedema (0% a 22%), redução da amplitude de movimento do ombro (3% a 16%), limitação na realização das atividades de vida diária (AVDs) (7,8% a 27,8%) e interferência na QV. Após 36 meses, as morbidades de membro superiores pouco interferiram na QV. As pacientes se preocuparam mais com o medo da recidiva. O tempo transcorrido da cirurgia e os instrumentos utilizados para a coleta dos dados explicam a variabilidade na prevalência de sintomas. Faltam estudos de acompanhamento de longo prazo para avaliar a evolução das morbidades e que avaliem a QV de pacientes brasileiras.INCA2009-03-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionRevisão de literaturaapplication/pdfhttps://rbc.inca.gov.br/index.php/revista/article/view/168110.32635/2176-9745.RBC.2009v55n1.1681Revista Brasileira de Cancerologia; Vol. 55 No. 1 (2009): Jan./Feb;/Mar.; 75-85Revista Brasileira de Cancerologia; Vol. 55 Núm. 1 (2009): ene./feb./mar.; 75-85Revista Brasileira de Cancerologia; v. 55 n. 1 (2009): jan./fev./mar.; 75-852176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAporhttps://rbc.inca.gov.br/index.php/revista/article/view/1681/992Velloso, Fernanda Saltiel Barbosa Barra, Alexandre de Almeida Dias, Rosângela Corrêa info:eu-repo/semantics/openAccess2021-11-29T20:21:28Zoai:rbc.inca.gov.br:article/1681Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2021-11-29T20:21:28Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false
dc.title.none.fl_str_mv Upper Limb Morbidity and Quality of Life After Lymph Node Sentinel Biopsy for Breast Cancer Treatment
Morbidade de Membros Superiores e Qualidade de Vida após a Biópsia de Linfonodo Sentinela para o Tratamento do Câncer de Mama
title Upper Limb Morbidity and Quality of Life After Lymph Node Sentinel Biopsy for Breast Cancer Treatment
spellingShingle Upper Limb Morbidity and Quality of Life After Lymph Node Sentinel Biopsy for Breast Cancer Treatment
Velloso, Fernanda Saltiel Barbosa
Neoplasias da mama
Biópsia de linfonodo sentinela
Morbidade
Qualidade de vida
Breast neoplasms
Sentinel lymph node biopsy
Morbidity
Quality of life
title_short Upper Limb Morbidity and Quality of Life After Lymph Node Sentinel Biopsy for Breast Cancer Treatment
title_full Upper Limb Morbidity and Quality of Life After Lymph Node Sentinel Biopsy for Breast Cancer Treatment
title_fullStr Upper Limb Morbidity and Quality of Life After Lymph Node Sentinel Biopsy for Breast Cancer Treatment
title_full_unstemmed Upper Limb Morbidity and Quality of Life After Lymph Node Sentinel Biopsy for Breast Cancer Treatment
title_sort Upper Limb Morbidity and Quality of Life After Lymph Node Sentinel Biopsy for Breast Cancer Treatment
author Velloso, Fernanda Saltiel Barbosa
author_facet Velloso, Fernanda Saltiel Barbosa
Barra, Alexandre de Almeida
Dias, Rosângela Corrêa
author_role author
author2 Barra, Alexandre de Almeida
Dias, Rosângela Corrêa
author2_role author
author
dc.contributor.author.fl_str_mv Velloso, Fernanda Saltiel Barbosa
Barra, Alexandre de Almeida
Dias, Rosângela Corrêa
dc.subject.por.fl_str_mv Neoplasias da mama
Biópsia de linfonodo sentinela
Morbidade
Qualidade de vida
Breast neoplasms
Sentinel lymph node biopsy
Morbidity
Quality of life
topic Neoplasias da mama
Biópsia de linfonodo sentinela
Morbidade
Qualidade de vida
Breast neoplasms
Sentinel lymph node biopsy
Morbidity
Quality of life
description The second most frequent cancer type worldwide and the most frequent in women is breast cancer. Sentinel lymph node biopsy (SLNB) has become a trend in therapeutic approach nowadays, once it allows disease control with minimal surgical intervention and grants low morbidity rates. This article aims at reviewing literature on musculoskeletal impairments and quality of life among women treated through SLNB for breast cancer. Pubmed, Cochrane, Scielo and Lilacs databases were searched through the years of 1997 to 2008. Medical subject heading terms uses were breast neoplasms, sentinel lymph node biopsy, morbidity and quality of life. Seventy six articles were retrieved and 22 were selected. Results showed the most studied morbidities were sensory disorders (7% to 88% prevalence), pain (3,5% to 39%), lymphedema (0% e 22%), shoulder range of motion impairment (3% to 16%), daily living activities restriction (7,8% to 27,8%) and quality of life deterioration. After 36 months upper limb morbidities hardly seem to interfere with quality of life. Patients have mostly worried about cancer recurrence. Surgery time lapsed and instruments used for data retrieving explain variability in symptoms prevalence. Long term follow-up studies to evaluate morbidities and quality of life research on Brazilian population are missing.
publishDate 2009
dc.date.none.fl_str_mv 2009-03-31
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Revisão de literatura
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/1681
10.32635/2176-9745.RBC.2009v55n1.1681
url https://rbc.inca.gov.br/index.php/revista/article/view/1681
identifier_str_mv 10.32635/2176-9745.RBC.2009v55n1.1681
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/1681/992
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv INCA
publisher.none.fl_str_mv INCA
dc.source.none.fl_str_mv Revista Brasileira de Cancerologia; Vol. 55 No. 1 (2009): Jan./Feb;/Mar.; 75-85
Revista Brasileira de Cancerologia; Vol. 55 Núm. 1 (2009): ene./feb./mar.; 75-85
Revista Brasileira de Cancerologia; v. 55 n. 1 (2009): jan./fev./mar.; 75-85
2176-9745
reponame:Revista Brasileira de Cancerologia (Online)
instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
instname_str Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron_str INCA
institution INCA
reponame_str Revista Brasileira de Cancerologia (Online)
collection Revista Brasileira de Cancerologia (Online)
repository.name.fl_str_mv Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
repository.mail.fl_str_mv rbc@inca.gov.br
_version_ 1797042247566360576

Registros relacionados